Celltrion Takes Aim At US Infliximab Market With Subcutaneous Launch

Korean Firm's Zymfentra Is First And Only SC Version Of Infliximab Approved By The FDA

 
• By Dave Wallace
  
Celltrion website logo
Celltrion has launched Zymfentra in the US • Source: Shutterstock

More from Products

More from Generics Bulletin